These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 37595489)
1. Association between local treatment modalities and event-free survival, overall survival, and local recurrence in patients with localised Ewing Sarcoma. Report from the Ewing 2008 trial. Heesen P; Ranft A; Bhadri V; Brichard B; Collaud S; Cyprova S; Eich H; Ek T; Gelderblom H; Hardes J; Haveman L; Jabar S; Hartmann W; Andreou D; Hauser P; Kersting J; Juergens H; Kanerva J; Kühne T; Raciborska A; Rascon J; Streitbürger A; Timmermann B; Uhlenbruch Y; Dirksen U Eur J Cancer; 2023 Oct; 192():113260. PubMed ID: 37595489 [TBL] [Abstract][Full Text] [Related]
2. Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial. Andreou D; Ranft A; Gosheger G; Timmermann B; Ladenstein R; Hartmann W; Bauer S; Baumhoer D; van den Berg H; Dijkstra PDS; Dürr HR; Gelderblom H; Hardes J; Hjorth L; Kreyer J; Kruseova J; Leithner A; Scobioala S; Streitbürger A; Tunn PU; Wardelmann E; Windhager R; Jürgens H; Dirksen U; Clin Orthop Relat Res; 2020 Feb; 478(2):290-302. PubMed ID: 31580267 [TBL] [Abstract][Full Text] [Related]
3. What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group - EWING1. Becker RG; Gregianin LJ; Galia CR; Jesus-Garcia Filho R; Toller EA; Badell G; Nakagawa SA; David A; Baptista AM; Yonamime ES; Serafini OA; Penna V; Santos JFC; Brunetto AL; BMC Cancer; 2017 Jun; 17(1):420. PubMed ID: 28619077 [TBL] [Abstract][Full Text] [Related]
4. Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G group. Foulon S; Brennan B; Gaspar N; Dirksen U; Jeys L; Cassoni A; Claude L; Seddon B; Marec-Berard P; Whelan J; Paulussen M; Streitbuerger A; Oberlin O; Juergens H; Grimer R; Le Deley MC Eur J Cancer; 2016 Jul; 61():128-36. PubMed ID: 27176931 [TBL] [Abstract][Full Text] [Related]
5. Nonmetastatic pelvic Ewing sarcoma: report of the French society of pediatric oncology. Carrie C; Mascard E; Gomez F; Habrand JL; Alapetite C; Oberlin O; Moncho V; Hoffstetter S Med Pediatr Oncol; 1999 Nov; 33(5):444-9. PubMed ID: 10531567 [TBL] [Abstract][Full Text] [Related]
6. Individual risk evaluation for local recurrence and distant metastasis in Ewing sarcoma: A multistate model: A multistate model for Ewing sarcoma. Bosma SE; Rueten-Budde AJ; Lancia C; Ranft A; Dirksen U; Krol AD; Gelderblom H; van de Sande MAJ; Dijkstra PDS; Fiocco M Pediatr Blood Cancer; 2019 Nov; 66(11):e27943. PubMed ID: 31389188 [TBL] [Abstract][Full Text] [Related]
7. Management and Outcome of Ewing Sarcoma of the Head and Neck. Grevener K; Haveman LM; Ranft A; van den Berg H; Jung S; Ladenstein R; Klco-Brosius S; Juergens H; Merks JH; Dirksen U Pediatr Blood Cancer; 2016 Apr; 63(4):604-10. PubMed ID: 26702872 [TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: a report from the Children's Oncology Group. DuBois SG; Krailo MD; Gebhardt MC; Donaldson SS; Marcus KJ; Dormans J; Shamberger RC; Sailer S; Nicholas RW; Healey JH; Tarbell NJ; Randall RL; Devidas M; Meyer JS; Granowetter L; Womer RB; Bernstein M; Marina N; Grier HE Cancer; 2015 Feb; 121(3):467-75. PubMed ID: 25251206 [TBL] [Abstract][Full Text] [Related]
10. Ewing sarcoma of the hand or foot. Froeb D; Ranft A; Boelling T; Paulussen M; Klco-Brosius S; Jürgens H; Dirksen U Klin Padiatr; 2012 Oct; 224(6):348-52. PubMed ID: 23143762 [TBL] [Abstract][Full Text] [Related]
11. The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas. Palmerini E; Colangeli M; Nanni C; Fanti S; Marchesi E; Paioli A; Picci P; Cambioli S; Donati D; Cevolani L; De Paolis M; Gambarotti M; Ferrari S Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):215-223. PubMed ID: 27645694 [TBL] [Abstract][Full Text] [Related]
12. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group. Donaldson SS; Torrey M; Link MP; Glicksman A; Gilula L; Laurie F; Manning J; Neff J; Reinus W; Thompson E; Shuster JJ Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):125-35. PubMed ID: 9747829 [TBL] [Abstract][Full Text] [Related]
13. Clinical Outcome of paediatric ewing sarcoma and significance of pathological necrosis for mortality after neoadjuvant chemotherapy: Single institutional study. Sindhu II; Mehreen A; Wali RM; Abubakar M J Pak Med Assoc; 2021 Oct; 71(10):2344-2349. PubMed ID: 34974568 [TBL] [Abstract][Full Text] [Related]
14. Multimodality treatment of pediatric Ewing sarcoma: A single-center 10-year analysis of outcomes. Jacobson JC; Clark RA; Cairo SB; Murphy JT; Chung DH Surgery; 2022 Oct; 172(4):1251-1256. PubMed ID: 35933175 [TBL] [Abstract][Full Text] [Related]
15. SCMCIE94: an intensified pilot treatment protocol known to be associated with cure in CD 56-negative non-pelvic isolated Ewing sarcoma (EWS) is also associated with no early relapses in non-metastatic extremity EWS. Cohen IJ; Toledano H; Stein J; Kollender Y; Fenig E; Konen O; Bar-Sever Z; Issakov J; Feinmesser M; Avigad S; Ash S Cancer Chemother Pharmacol; 2019 May; 83(5):859-866. PubMed ID: 30770960 [TBL] [Abstract][Full Text] [Related]
16. Long-term Outcomes and Complications in Pediatric Ewing Sarcoma. Hamilton SN; Carlson R; Hasan H; Rassekh SR; Goddard K Am J Clin Oncol; 2017 Aug; 40(4):423-428. PubMed ID: 25599318 [TBL] [Abstract][Full Text] [Related]
17. Extraskeletal versus Skeletal Ewing Sarcoma in the adult population: Controversies in care. Lynch AD; Gani F; Meyer CF; Morris CD; Ahuja N; Johnston FM Surg Oncol; 2018 Sep; 27(3):373-379. PubMed ID: 30217290 [TBL] [Abstract][Full Text] [Related]
18. Complete tumor necrosis after neoadjuvant chemotherapy defines good responders in patients with Ewing sarcoma. Lozano-Calderón SA; Albergo JI; Groot OQ; Merchan NA; El Abiad JM; Salinas V; Gomez Mier LC; Montoya CS; Ferrone ML; Ready JE; Linares FJ; Levin AS; Peleteiro Pensado M; Pozo Kreilinger JJ; Ruiz IB; Ortiz-Cruz EJ; Gebhardt MC; Cote GM; Choy E; Spentzos D; Hung YP; Deshpande V; Chebib IA; McCulloch RA; Farfalli G; Aponte Tinao L; Morris CD; Petur Nielsen G; Anderson ME; Jeys LM Cancer; 2023 Jan; 129(1):60-70. PubMed ID: 36305090 [TBL] [Abstract][Full Text] [Related]